{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["6(10)"],"submitter":["Liu H"],"journal":["MedComm"],"pagination":["e70427"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12501409"],"repository":["biostudies-literature"],"pubmed_title":["Efficacy of Disitamab Vedotin and Immune Profiles in High-Risk Non-Muscle-Invasive Bladder Cancer With HER2 Overexpression."],"pmcid":["PMC12501409"],"pubmed_authors":["Liu H","Chen J","Zhang M","Zeng H","Chuang Y","Sun G","Zhu Q"],"additional_accession":[]},"is_claimable":false,"name":"Efficacy of Disitamab Vedotin and Immune Profiles in High-Risk Non-Muscle-Invasive Bladder Cancer With HER2 Overexpression.","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Oct","modification":"2026-06-04T10:03:46.623Z","creation":"2026-06-02T03:07:52.057Z"},"accession":"S-EPMC12501409","cross_references":{"pubmed":["41064127"],"doi":["10.1002/mco2.70427"]}}